Clinical Trial Update: Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports dose–response results for lasofoxifene in postmenopausal osteoporosis, focusing on a Japanese/Asian population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Lasofoxifene (Lasofoxifene)

Snippet

Sponsor: Ligand Pharmaceuticals | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED